Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-19

Clinical Trial Update: Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning [NA]

View source ↗

Summary

Completed clinical trial evaluating Behavioral Activation for medication-responsive chronic depression with impaired social functioning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Persistent Depressive Disorder | NA | Status: COMPLETED | Results posted: 2017-06-19